Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-24-077794
Filing Date
2024-09-11
Accepted
2024-09-11 17:47:00
Documents
1
Period of Report
2024-09-09

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3120
  Complete submission text file 0001213900-24-077794.txt   4610
Mailing Address 99 BELBROOK WAY ATHERTON CA 94027
Business Address
CASAMENTO CHARLES J (Reporting) CIK: 0001117167 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39082 | Film No.: 241293423

Mailing Address 2222 PONCE DE LEON BLVD. 3RD FLOOR CORAL GABLES FL 33134
Business Address 2222 PONCE DE LEON BLVD. 3RD FLOOR CORAL GABLES FL 33134 646 876 3459
RELMADA THERAPEUTICS, INC. (Issuer) CIK: 0001553643 (see all company filings)

EIN.: 455401931 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)